C6ORF211 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.836800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.927200E-01
Normal-vs-Stage2
5.859400E-01
Normal-vs-Stage3
8.247600E-02
Normal-vs-Stage4
9.503000E-01
Stage1-vs-Stage2
4.719800E-01
Stage1-vs-Stage3
3.132800E-01
Stage1-vs-Stage4
9.587400E-01
Stage2-vs-Stage3
2.414200E-01
Stage2-vs-Stage4
4.844000E-01
Stage3-vs-Stage4
1.241600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.528800E-01
Normal-vs-AfricanAmerican
8.339800E-01
Normal-vs-Asian
5.789400E-01
Caucasian-vs-AfricanAmerican
2.738200E-01
Caucasian-vs-Asian
7.845200E-01
AfricanAmerican-vs-Asian
3.554000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.233800E-01
Normal-vs-Female
7.721400E-01
Male-vs-Female
1.362050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.939200E-01
Normal-vs-Age(41-60Yrs)
8.501000E-01
Normal-vs-Age(61-80Yrs)
4.929000E-01
Normal-vs-Age(81-100Yrs)
5.925000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.537000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.996200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.519400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.281500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.705000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.620800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.066200E-01
Normal-vs-Daily Drinker
1.838410E-01
Normal-vs-Weekly Drinker
8.746600E-01
Normal-vs-Occasional Drinker
6.703600E-01
Normal-vs-Social Drinker
3.502200E-01
Non Drinker-vs-Daily Drinker
2.452000E-01
Non Drinker-vs-Weekly Drinker
5.874400E-01
Non Drinker-vs-Occasional Drinker
3.824800E-01
Non Drinker-vs-Social Drinker
8.204200E-01
Daily Drinker-vs-Weekly Drinker
2.739400E-01
Daily Drinker-vs-Occasional Drinker
6.443900E-02
Daily Drinker-vs-Social Drinker
4.391400E-01
Weekly Drinker-vs-Occasional Drinker
9.281200E-01
Weekly Drinker-vs-Social Drinker
5.222800E-01
Occasional Drinker-vs-Social Drinker
3.292200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.999000E-01
Normal-vs-Grade 2
7.160200E-01
Normal-vs-Grade 3
7.039600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.623200E-01
Grade 1-vs-Grade 3
7.654400E-01
Grade 1-vs-Grade 4
4.999000E-01
Grade 2-vs-Grade 3
7.924200E-01
Grade 2-vs-Grade 4
7.160200E-01
Grade 3-vs-Grade 4
7.039600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.500800E-01
Normal-vs-NonDiabetic
5.319000E-01
Diabetic-vs-NonDiabetic
2.446600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.342600E-01
Normal-vs-NoPancreatitis
4.924400E-01
Pancreatitis-vs-NoPancreatitis
9.180400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.347800E-01
Normal-vs-N1
5.805000E-01
N0-vs-N1
8.648600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.362800E-01
Normal-vs-TP53-NonMutant
7.507200E-01
TP53-Mutant-vs-TP53-NonMutant
8.403000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
